The Digital Source For China's Tech Innovation Since 2000

Search
Close this search box.

Insite, North American’s first safe injection site, turns 20 as overdose crisis evolves

September 15, 2023
Source: theglobeandmail.com theglobeandmail.com
News Snapshot:
Open this photo in gallery: In 2008, a man pauses to look at 1,000 crosses during a vigil at Crab Park in Vancouver's Downtown Eastside. The crosses represent the lives saved by Insite, a supervised injection clinic that opened in the neighbourhood five years earlier.Jonathan Hayward/The Canadian Press In 2003, Vancouver was in the throes of a double-barrelled public health crisis. British Columbia had suffered a surge in overdose deaths, the majority of them in its biggest city, and an explosion of HIV and hepatitis C cases was disproportionately devastating the city’s injection drug users, the result of sharing syringes....
Go To Original Source →
Tags: Activist | addiction | AIDS | Alcoholic Beverage | ARM | Britain | bus | Canada | Chinese | Coffee | college | community | court | crime | data | drug | drugs | education | emergency | Europe | executive | facility | Germany | government | health

Other Related News:

Got $1,000? 3 Top Canadian Stocks to Buy in December

December 6, 2023

Tacko Fall goes viral with murderous poster dunk in Chinese basketball league

December 6, 2023

India redefining need for regulations on data protection, BJP’s Baijayant Panda says at tech summit

December 6, 2023

BYD plots path to Australian domination

December 6, 2023

20-minute treatment found to improve brains of Alzheimer's patients

December 6, 2023

Investors deliver $40M to B.C. food service platform Fantuan

December 6, 2023

DVYE: 10% Yield With 3 Red Flags

December 6, 2023

Houyi Digital Begins $100 Million U.S. IPO Effort

December 6, 2023

Smart returns with sleek #3 but is it really a Smart at all?

December 6, 2023
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
© 2023 ChinaTechNews.com. A Service of Asia Media Network.
Twitter